↓ Skip to Main Content
Thasso
Thasso the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs

search: thasso

Log in

Main Navigation

  • english
    • english
    • français
    • deutsch
    • italiano
    • español
    • português
  • thasso
  • thasso post
  • thasso toolbox
    • theragenomics: useful links
    • theragenomics: biomarkers
    • theragenomics: companion tests
    • theragenomics: drug labels with annotated information
    • theragenomics: drugs and genes
    • theragenomics: the world of alleles
    • theragenomics: allele-related guideline information
    • drug interactions
    • drug information
    • drug adverse reactions
    • drugs: risk evaluation and mitigation strategies (REMS)
    • theragenomics: videos
  • thasso academy
    • health authorities
    • patient & consumer health
    • public domain
      • Swiss Academy of Medical Sciences
      • EUPATI The European Patients’ Academy on Therapeutic Innovation
    • companies
    • products
    • about
  • thasso community
    • thasso: simple chat
    • thasso: video chat
    • theragenomics: survey at thasso
      • survey participants
    • forum
      • patient groups / subgroups
      • group
      • lounge
      • events
      • gallery
  • thasso: about
    • vision
    • background
    • the apomediary patient
    • contact
    • disclaimers
    • policies
  • donations
    • thasso – thank you
    • Donation Confirmation

Tag: Vasculogenesis

Increased Risk Of Aneurysms And Artery Dissections With VEGF Inhibitors

By Joseph Gut - thasso Posted on August 26, 2020 Posted in Adverse Drug Reaction [ADR], Regulatory Announcement, Thasso Post, Theragenomic Medicine Tagged with Age-Related Macular Degeneration, Aneurysm, Angiogenesis, Artery Dissection, Axitinib (Inlyta), Bevacizumab [Avastin], Bevacizumab-awwb (Mvasi), Bevacizumab-bvzr (Zirabev), Cabozantinib (Cabometyx), Cabozantinib (Cometriq), Cancer, DrugInjuryWatch.com, FDA Adverse Event Reporting System (FAERS), Individual Case Safety Report (ICSR), Lenvatinib (Lenvima), Medicines and Healthcare products Regulatory Agency (MHRA), Nintedanib [Ofev], Pazopanib [Votrient], Ponatinib (Iclusig), Ramucirumab [Cyramza], Regorafenib (Stivarga), Retina, Sorafenib tosylate (Nexavar), Sunitinib malate (Sutent), Tom Lamb, Vandetanib (Caprelsa), Vascular Endothelial Growth Factor (VEGF), Vasculogenesis, VEGF Inhibitor, VigiBase, Ziv-aflibercept (Zaltrap)
Increased Risk Of Aneurysms And Artery Dissections With VEGF Inhibitors

August 26 2020 –  Vascular endothelial growth factor (VEGF), originally known as vascular permeability factor (VPF)  is a signal protein produced by cells that stimulates the formation of blood vessels. VEGF is a sub-family of growth factors, the platelet-derived growth factor …

Increased Risk Of Aneurysms And Artery Dissections With VEGF Inhibitors Read more »

Footer Menu

  • english
  • thasso
  • thasso post
  • thasso toolbox
  • thasso academy
  • thasso community
  • thasso: about
  • donations
Copyright © 2025 Thasso | Powered by Responsive Theme